Blackstone Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
181
Total Value
24079232251
Accession Number
0000950123-25-005761
Form Type
13F-HR
Manager Name
Blackstone Inc.
Data Enrichment
86% identified
155 identified26 unidentified

Holdings

181 positions
Manager:
Search and click to pin securities to the top
Page 5 of 9
SUBURBAN PROPANE PARTNERS LP
Shares:
412061(+0.0%)
Value:
$8.7B(+22.1%)
GLOBAL PARTNERS LP
Shares:
152104(+0.0%)
Value:
$8.1B(+14.7%)
Oruka Therapeutics, Inc.
Shares:
783653(+226.3%)
Value:
$8.0B(+72.7%)
CommScope Holding Company, Inc.
Shares:
1500000
Value:
$8.0B
Spyre Therapeutics, Inc.
Shares:
489248(+8.9%)
Value:
$7.9B(-24.5%)
Protara Therapeutics, Inc.
Shares:
1744042(+3.8%)
Value:
$7.4B(-16.2%)
92333F101
Shares:
701603
Value:
$7.2B
012653200
Shares:
200000(+0.0%)
Value:
$7.1B(-12.4%)
Viking Holdings Ltd
Shares:
175000(-66.7%)
Value:
$7.0B(-69.9%)
86745KAH7
Shares:
0
Value:
$6.9B(-59.4%)
Apogee Therapeutics, Inc.
Shares:
183747(+129.7%)
Value:
$6.9B(+89.4%)
Nextracker Inc.
Shares:
139188
Value:
$5.9B
Apple Hospitality REIT, Inc.
Shares:
446900(+0.0%)
Value:
$5.8B(-15.9%)
78781J109
Shares:
300000
Value:
$5.6B
Waystar Holding Corp.
Shares:
150000
Value:
$5.6B
485924104
Shares:
165000
Value:
$5.5B
FIRST SOLAR, INC.
Shares:
41900(+3450.8%)
Value:
$5.3B(+2447.3%)
Enphase Energy, Inc.
Shares:
82602
Value:
$5.1B
Rezolute, Inc.
Shares:
1744740(+0.0%)
Value:
$5.1B(-40.8%)
Inhibikase Therapeutics, Inc.
Shares:
2070684(+0.0%)
Value:
$4.5B(-32.6%)